2016 Publications

Specialist-led diabetes registries and prevalence of poor glycemic control in type 2 diabetes: The diabetes registry outcomes project for A1C reduction (DROP A1C)

To highlight the utility of a large patient registry to identify functionally refractory
patients (persistent HbA1c ‡75 mmol/mol [9.0%]) with type 2 diabetes, identify their barriers to glycemic control, and implement barrier-specific care path strategies to improve glycemic control.

Specialist-Led Diabetes Registries and Prevalence of Poor Glycemic Control in Type 2 Diabetes: The Diabetes Registry Outcomes Project for A1C Reduction (DROP A1C)

The need associated with diabetes primary care and the impact of referral to a specialist-centered multidisciplinary diabetes program (the NADIR Study)

The impact of specialist care on glycemia and cardiovascular risk factors in patients with diabetes is uncertain. This observational cohort study investigated metabolic risk factors in patients referred to LMC Diabetes & Endocrinology for diabetes management.

Rates and predictors of hypoglycemia in 27,585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study

There is a lack of data on the prevalence of hypoglycaemia in developed and developing countries. This study aimed to determine the global extent of hypoglycaemia experienced by patients with diabetes using insulin.

Rates and predictors of hypoglycaemia in 27,585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial

To compare insulin pump therapy and multiple daily injections (MDI) in patients with type 2 diabetes receiving basal and prandial insulin analogues.

Randomized trial of long-acting insulin glargine titration web tool (LTHome) versus enhanced usual therapy of glargine titration (INNOVATE trial)

Basal insulin titration in the real world is often unsuccessful. LTHome, a web tool, applies a rules engine-based algorithm providing insulin titration advice directly to the patient.

Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE Trial)